cancer biosimilars

Views & Analysis

Adrian van den Hoven of Medicines for Europe addresses three big questions facing the biosmilars sector in Europe in 2018.

News

In a handful of strongly-worded warning letters, the FDA is cracking down on sales of unapproved peptides - even if they're labelled for research.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.